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MEFV gene is a probable susceptibility gene for Behçet’s disease
N Imırzalıoglu1, A Dursun2, B Tastan3, Y Soysal1, MC Yakıcıer4
Departments of 1Medical Genetics and 3Dermatology, Military Medical Academy, Ankara, 2Department of Medical Genetics, Zonguldak
Karaelmas University, Zonguldak, 4Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
Objective: Behçet’s disease (BD) is a rare, chronic, multisystem inflammatory disorder. The prevalence of BD is
higher in the Middle Eastern and Mediterranean populations. Another chronic inflammatory disease, familial
Mediterranean fever (FMF), is also known to be highly prevalent in these populations. The prevalence of BD is
higher in the FMF patient population than in populations known to be rich in BD . Both BD and FMF have
some pathophysiological features in common and they result from inappropriate activation of neutrophils.
Clinical manifestations of both diseases can mimic each other and the coexistence of both diseases in the same
patient has been reported. Given that BD and FMF have similar pathophysiological, epidemiological, and
clinical features, we hypothesized that the gene responsible for FMF, MEFV, may also play a role in the
pathogenesis of BD.
Methods: Forty-two BD patients who had no symptoms and family history for FMF and 66 healthy controls
were screened for common MEFV gene mutations (E148Q, M680I, M694V, and V726A).
Results: Fifteen patients (36%) displayed MEFV mutations (nine M694V, five E148Q, and one M680I) and
mutation rates were significantly elevated compared to 66 (11%) healthy controls (p50.0034).
Conclusion: The occurrence of frequent MEFV mutations in BD patients suggests that the MEFV gene is
involved in the pathogenesis of Behçet’s disease.
Behçet’s disease (BD) is a recurrent inflammatory
condition characterized by oral and genital ulcera-
tion, uveitis, skin lesions, increased risk of developing
thrombosis, and central nervous system involvement.
Familial Mediterranean fever (FMF) is an autosomal
recessive and is also known as an autoinflammatory
disease characterized by recurrent episodes of appar-
ently unprovoked inflammation. However, unlike
other autoimmune disorders, FMF lacks the produc-
tion of high-titre autoantibodies or antigen-specific
T-cells (1). Both BD and FMF are known to be
highly prevalent in Middle Eastern and Mediter-
ranean populations (2, 3). The gene responsible for
FMF, designated MEFV, was identified in 1997 by
positional cloning (4). MEFV encodes a 781 amino
acid protein, pyrin, that is predominantly expressed
in polymorphonuclear leukocytes (PMNs) and
cytokine-activated monocytes (5). Pyrin consists of
four functional domains, a B-box zinc-finger domain,
a coiled-coil domain, a C-terminal B30.2 domain,
and a 92 amino acid N-terminal PYRIN domain that
is shared by a number of other proteins involved in
apoptosis and inflammation (6). The antiinflammatory
role of pyrin is further evidenced by identification of
mutations in CD2 binding protein 1 (CD2BP1) and
its interaction with pyrin (7).
In BD, the underlying pathology is believed to be
vasculitis with immune complex deposition. This
inflammation may relate to other autoinflammatory
conditions and their suggested mechanisms. BD is
not a Mendelian disorder; however, considering its
occasional familial presentation and its close associa-
tion with genes of major histocompatibility com-
plexes, BD is under some sort of genetic control (8).
Therefore, this study was designed to investigate
whether there is any correlation between BD and
pyrin gene mutations.
Material and methods
Forty-two patients with BD and 66 controls who
were all Turkish were included in this study. Patients
with BD were clinically and serologically diagnosed
by the Department of Dermatology, Gulhane
Military Medical Academy, and all fulfilled three or
more International Study Group (ISG) criteria for
BD (9). They were not symptomatic for FMF and
did not have a family history of FMF. Eleven out of
42 patients were female and the mean age of the
patients was 32 years. The 66 controls were all
healthy and had no symptoms for either FMF or BD.
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Fourteen of the 66 controls were female and the
mean age of the controls was 34 years. Informed
consent was obtained from all patients and controls
that participated in this study.
Blood samples from patients and controls were
taken at the Medical Genetics Department, Gulhane
Military Medical Academy. DNA extraction was
undertaken using the QIAampH DNA Mini Kit
(QIAGEN Cat. No. 51306) according to the manu-
facturer’s instructions. Four pyrin gene mutations
(E148Q, M680I, M694V, and V726A) were detected
from patients and controls by using the PRONTOTM
FMF Basic Kit (Sayvon Diagnostic Ltd. Cat.
No. 9904) according to the manufacturer’s
instructions.
Allele frequencies were compared with the x2-test
and Fisher’s exact x2-test (SPSS for Windows 11.0).
Significance was assigned to p values v 0.05.
Results
Pyrin gene mutations were found in 15 (three female
and 12 male) patients and seven (two female and
five male) controls (36% and 11%, respectively).
Mutation V726A was not found in any of the groups.
In the patients with BD, nine out of 42 (21%) had an
M694V mutation (three homozygotes), five (12%)
had an E148Q mutation and one (2%) had an M680I
mutation. In the control group, four out of 66 (6%)
had an M694V mutation, one (2%) had an E148Q
mutation and two (3%) had M680I mutation
(Table 1). The difference in mutation frequency for
the pyrin gene between the patient group and the
control group was statistically significant (p50.0034).
When distribution was compared between patients
and controls, the frequency of the M694V mutation
was significantly higher in the patient group than
the controls (p50.0367). In addition, mutation
E148Q frequency was also significantly higher in
the patient group than the controls (p50.0321). The
frequency of the M680I mutation was not statisti-
cally significant.
Discussion
BD is a chronic, inflammatory, multisystemic dis-
order with unknown aetiology. Because the pathog-
nomonic clinical features and tools are absent, the
diagnosis of BD relies mainly on its characteristic
clinical features and the judgement of the experienced
physician. Recent advances in molecular genetics and
identification of disease genes have made it possible
to correlate disease pathogenesis with genotype.
Studies concerning the relationship between auto-
inflammatory disease and suspected genes may help
to explain the pathogenesis. An autoinflammatory
disease characterized by recurrent episodes of appar-
ently unprovoked inflammation, but unlike other
autoimmune disorders, lacks the production of high-
titre autoantibodies or antigen-specific T-cells, may
have a different inflammatory mechanism. The gene
pyrin is predominantly expressed in PMNs and
cytokine-activated monocytes (5). Recent advances
showed that pyrin consists of four functional
domains (the PYRIN domain, a B-box zinc-finger
domain, a coiled-coil domain, and a C-terminal
B30.2 domain), and the PYRIN domain is shared
by a number of proteins involved in apoptosis and
inflammation and is a member of the six-helix
bundle, death-domain super family that includes
death domains, death effector domains, and caspase
recruitment domains (CARDs) (10). Like other
members of this super family, the PYRIN domain
appears to allow for the interaction, or assembly,
of macromolecular complexes by PYRIN–PYRIN
interactions (11, 12). The antiinflammatory role of
pyrin has been further evidenced by the identification
of mutations in CD2BP1 (also referred to as proline,
serine, threonine phosphatase interacting protein,
PSTPIP1) (7). Mutations in CD2BP1 result in the
autosomal dominant PAPA syndrome, which is
characterized by severe, destructive, early-onset
inflammation of the joints, skin, and muscle (8, 13).
In addition, mutations in another pyrin-related
protein, cryopyrin, are associated with Muckle–
Wells/familial cold urticaria and chronic infantile
neurological cutaneous and articular syndrome (14).
Touitou et al have previously investigated the
relationship between the MEFV gene and BD (15). In
their study, 15 of 38 patients with BD were from
ancestry with a high risk for FMF disease and three
mutations on the pyrin gene (M694V, V726A, and
E148Q) were detected in the patient group with a
frequency of 2.6%, 2.6%, and 5.2%, respectively. In
comparison to this study, frequencies in our findings
are much higher. This could be explained by the
differences in patient population and methodology
chosen in the two studies. In addition, two other
studies concerning BD and the MEVF gene mutation
reported a clinical and genetic correlation (16, 17).
Atagunduz et al also reported that 26% of BD
Table 1. Distribution and p value of mutations in control and
patient groups. p values were calculated by the x2-test and Fisher’s





Mutation frequency 15/27 7/59 0.0034
M694V 9(3*)/33 4/62 0.0367
E148Q 5/37 1/65 0.0321
M680I 1/41 2/64 0.9999
*Homozygous.

































patients were found to carry one single MEFV
mutation, compared to 9.1% in the control group
(17).
We propose that MEFV gene mutations have a
role in inflammation in general and could be an
additional susceptibility genetic factor in BD. In our
study, four mutations (E148Q, M680I, M694V, and
V726A) were screened and the statistical findings
may be further supported by sequencing all coding
regions of the pyrin gene for newer mutations,
especially the PYRIN domain, which is located at
the second to 92nd amino acids of the pyrin gene.
References
1. Galon J, Aksentijevich I, McDermott MF, O’Shea JJ,
Kastner DL. TNFRSF1A mutations and autoinflammatory
syndromes. Curr Opin Immunol 2000;12:479–86.
2. Heller H, Sohar E, Sherf L. Familial Mediterranean fever
(FMF). Arch Int Med 1958;102:50–71.
3. Mizuki N, Ota M, Kimura M, Ohno S, Ando H,
Katsuyama M, et al. Triplet repeat polymorphism in the
transmembrane region of the MICA gene: a strong association
of six GCT repetitions with Behçet disease. Proc Natl Acad Sci
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